Moderna
MRNA
MRNA
737 hedge funds and large institutions have $11.5B invested in Moderna in 2024 Q4 according to their latest regulatory filings, with 143 funds opening new positions, 229 increasing their positions, 251 reducing their positions, and 170 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
16% less first-time investments, than exits
New positions opened: 143 | Existing positions closed: 170
20% less call options, than puts
Call options by funds: $929M | Put options by funds: $1.16B
34% less capital invested
Capital invested by funds: $17.4B → $11.5B (-$5.92B)
Holders
737
Holding in Top 10
8
Calls
$929M
Puts
$1.16B
Top Buyers
| 1 | +$124M | |
| 2 | +$117M | |
| 3 | +$83M | |
| 4 |
D.E. Shaw & Co
New York
|
+$62.8M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$53.3M |
Top Sellers
| 1 | -$148M | |
| 2 | -$127M | |
| 3 | -$77.8M | |
| 4 |
JP Morgan Chase
New York
|
-$70.8M |
| 5 |
NAMA
Nikko Asset Management Americas
New York
|
-$56.8M |